Ledger.Open graph →
SEC Form D · filed September 22, 2014

Eureka Therapeutics Inc

Offering
$21.0M
Sold
$21.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Emeryville, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Nick B. Margarites · Washington, Washington, D.C.Exec · DirectorVictor S. Pompino · NORWALK, CTDirectorHsing Kung · Santa Clara, CADirectorQiushi Fu · Beijing, IsraelDirectorChih-Kai Cheng · Taipei, F5DirectorIsaac Flattau · New York, NYExec · DirectorJeffrey C. Seller · New York, NYDirectorHsing Kung · Emeryville, CADirectorQiushi Fu · Emeryville, CADirectorChih-Kai Cheng · Santa Clara, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗